Lithium is a standard first‐line treatment for bipolar disorder and one of the recommended augmenting agents for treatment‐resistant depression. However, concerns remain about the long‐term organ toxicity of this drug, mainly renal adverse effec...
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=O119876235
2019년
-
1367-7543
1931-227X
SCOPUS;ESCI
학술저널
19-21 [※수록면이 p5 이하이면, Review, Columns, Editor's Note, Abstract 등일 경우가 있습니다.]
0
상세조회0
다운로드다국어 초록 (Multilingual Abstract)
Lithium is a standard first‐line treatment for bipolar disorder and one of the recommended augmenting agents for treatment‐resistant depression. However, concerns remain about the long‐term organ toxicity of this drug, mainly renal adverse effec...
Lithium is a standard first‐line treatment for bipolar disorder and one of the recommended augmenting agents for treatment‐resistant depression. However, concerns remain about the long‐term organ toxicity of this drug, mainly renal adverse effects. Here, Dr Gupta and colleagues discuss their local audit of administering lithium in CKD patients and how the results were used to inform trust policy and improve clinical practice.
Equivalence of mental and physical illness: the paradox of provision
Factitious disorder: a case report and literature review of treatment
Diagnostic overshadowing in learning disability: think beyond the disability
A case of limbic encephalitis with initial presentation of chills